Form NPORT-P Nuveen AMT-Free Quality For: Jan 31
Tweet
Share
E-mailSerious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Announces U.S. FDA Approval of GENGLYCOS™ Gene Therapy, the First-Ever FDA-Approved Treatment Designed to Treat the Underlying Cause of Glycogen Storage Disease Type Ia (GSDIa)
- Myriad Uranium Corp. and Rush Rare Metals Corp. Announce Receipt of Final Court Approval for Plan of Arrangement
- Gibbs & Crivelli Injury Attorneys Rebrands as Slingshot Law - Injury Attorneys
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
